Conformational studies of plasminogen activator inhibitor type 1 by fluorescence spectroscopy. Analysis of the reactive centre of inhibitory and substrate forms, and of their respective reactive-centre cleaved forms

European Journal of Biochemistry

Volumn 267, Issue 12, 2000, Pages 3729-3734

  Fa, Ming ^b   Bergström, Fredrik ^b   Karolin, Jan ^b   Johansson, Lennart B Å ^b   Ny, Tor ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b NONE

Author keywords

Conformation; Donor donor energy migration; Fluorescence; Plasminogen activator inhibitor

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; FLUORESCENCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

BORON COMPOUNDS; FLUORESCENT DYES; MODELS, MOLECULAR; MUTATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN CONFORMATION; SPECTROMETRY, FLUORESCENCE;

EID: 0001252527     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01406.x     Document Type: Article

References (39)

1. 1. Huber, R. & Carrell, R.W. (1989) Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry 28, 8951-8966.
2. 2. Potempa, J., Korzus, E. & Travis, J. (1994) The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269, 15957-15960.
3. 3. Gils, A. & Declerck, P.J. (1998) Structure-function relationships in serpins: Current concepts and controversies. Thromb. Haemost. 80, 531-541.
4. 4. Carrell, R.W. & Evans, D.L.I. (1992) Serpins: mobile conformations in a family of proteinase inhibitors. Curr. Opin. Struct. Biol. 2, 438-446.
5. 5. Gettins, P.G.W., Patston, P.A. & Schapira, M. (1993) The role of conformational change in serpin structure and function. Bioessays 15, 461-467.
6. 6. Nilsson, T. & Wiman, B. (1982) On the structure of the stable complex between plasmin and alpha-2-antiplasmin. FEBS Lett. 142, 111-114.
7. 7. Lawrence, D.A., Ginsburg, D., Day, D.E., Berkenpas, M.B., Verhamme, I.M., Kvassman, J.O. & Shore, J.D. (1995) Serpin-protease complexes are trapped as stable acyl-enzyme intermediates. J. Biol. Chem. 270, 25309-25312.
8. 8. Wilczynska, M., Fa, M., Ohlsson, P.I. & Ny, T. (1995) The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex. J. Biol. Chem. 270, 29652-29655.
9. 9. Shore, J.D., Day, D.E., Francis-Chmura, A.M., Verhamme, I., Kvassman, J., Lawrence, D.A. & Ginsburg, D. (1995) A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism. J. Biol. Chem. 270, 5395-5398.
10. 10. Wilczynska, M., Fa, M., Karolin, J., Ohlsson, P.I., Johansson, L.B.-Å. & Ny, T. (1997) Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat. Struct. Biol. 4, 354-357.
11. 11. Stratikos, E. & Gettins, P.G.W. (1998) Mapping the serpin-proteinase complex using single cysteine variants of α-proteinase inhibitor Pittsburgh. J. Biol. Chem. 273, 15582-15589.
12. 12. Stratikos, E. & Gettins, P.G.W. (1999) Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into β-sheet A. Proc. Natl Acad. Sci. USA 96, 4808-4813.
13. 13. Fa, M., Bergström, F., Hägglöf, P., Wilczynska, M., Johansson, L.B.-Å. & Ny, T. (2000) The structure of a serpin-protease complex revealed by intramolecular distance measurements using donor-donor energy migration and mapping of interaction sites. Structure 8, 397-405.
14. 14. Olson, S.T. (1985) Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin. J. Biol. Chem. 260, 10153-10160.
15. 15. Patston, P.A., Gettins, P.G.W., Beechem., J. & Schapira, M. (1991) Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate. Biochemistry 30, 8876-8882.
16. 16. Hopkins, P.C., Carrell, R.W. & Stone, S.R. (1993) Effects of mutations in the hinge region of serpins. Biochemistry 32, 7650-7657.
17. 17. Hood, D.B., Huntington, J.A. & Gettins, P.G.W. (1994) Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways. Biochemistry 33, 8538-8547.
18. 18. Huntington, J.A., Fan, B., Karlsson, K.E., Deinum, J., Lawrence, D.A. & Gettins, P.G.W. (1997) Serpin conformational change in oval-bumin. Enhanced reactive center loop insertion through hinge region mutations. Biochemistry 36, 5432-5440.
19. 19. Loskutoff, D.J., Sawdey, M. & Mimuro, J. (1989) Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb. 9, 87-115.
20. 20. Chmielewska, J., Ranby, M. & Wiman, B. (1988) Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions. Biochem. J. 251, 327-332.
21. 21. Urano, T., Strandberg, L., Johansson, L.B.-Å. & Ny, T. (1992) A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate. Eur. J. Biochem. 209, 985-992.
22. 22. Munch, M., Heegaard, C.W. & Andreasen, P.A. (1993) Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor. Biochim. Biophys. Acta 1202, 29-37.
23. 23. Kjoller, L., Martensen, P.M., Sottrup Jensen, L., Justesen, J., Rodenburg, K.W. & Andreasen, P.A. (1996) Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1. Eur. J. Biochem. 241, 38-46.
24. 24. Andreasen, P.A., Egelund, R., Jensen, S. & Rodenburg, K.W. (1999) Solvent effects on activity and conformation of plasminogen activator inhibitor-1. Thromb. Haemost. 81, 407-414.
25. 25. Lawrence, D.A., Olson, S.T., Palaniappan, S. & Ginsburg, D. (1994) Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition. J. Biol. Chem. 269, 27657-27662.
26. 26. Audenaert, A.M., Knockaert, I., Collen, D. & Declerck, P.J. (1994) Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop. J. Biol. Chem. 269, 19559-19564.
27. 27. Tucker, H.M., Mottonen, J., Goldsmith, E.J. & Gerard, R.D. (1995) Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition. Nat. Struct. Biol. 2, 442-445.
28. 28. Fa, M., Karolin, J., Aleshkov, S., Strandberg, L., Johansson, L.B.-Å. & Ny, T. (1995) Time-resolved polarized fluorescence spectroscopy studies of plasminogen activator inhibitor type 1: conformational changes of the reactive center upon interactions with target proteases, vitronectin and heparin. Biochemistry 34, 13833-13840.
29. 29. Aleshkov, S.B., Fa, M., Karolin, J., Strandberg, L., Johansson, L.B.-Å., Wilczynska, M. & Ny, T. (1996) Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1. The distance between P3 and P1′ determined by donor-donor fluorescence energy transfer. J. Biol. Chem. 271, 21231-21238.
30. 30. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K. & Pease, L.R. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.
31. 31. Lawrence, D.A., Strandberg, L., Ericson, J. & Ny, T. (1990) Structure-function studies of the SERPIN plasminogen activator inhibitor type I. Analysis of chimeric strained loop mutants. J. Biol. Chem. 265, 20293-20301.
32. 32. Lawrence, D., Strandberg, L., Grundstrom, T. & Ny, T. (1989) Purification of active human plasminogen activator inhibitor I from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells. Eur. J. Biochem. 186, 523-533.
33. 33. Karolin, J., Fa, M., Wilczynska, M., Ny, T. & Johansson, L.B.-Å. (1998) Donor-donor energy migration for determining intramolecular distances in proteins: I. Application of a model to the latent plasminogen activator inhibitor-1 (PAI-1). Biophys. J. 74, 11-21.
34. 34. Aertgeerts, K., De Bondt, H.L., De Ranter, C. & Declerck, P.J. (1994) A model of the reactive form of plasminogen activator inhibitor-1. J. Struct. Biol. 113, 239-245.
35. 35. Mottonen, J., Strand, A., Symersky, J., Sweet, R.M., Danley, D.E., Geoghegan, K.F., Gerard, R.D. & Goldsmith, E.J. (1992) Structural basis of latency in plasminogen activator inhibitor-1. Nature 355, 270-273.
36. 36. Declerck, P.J., De Mol, M., Vaughan, D.E. & Collen, D. (1992) Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator. J. Biol. Chem. 267, 11693-11696.
37. 37. Kvassman, J.O., Verhamme, I. & Shore, J.D. (1998) Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1. Biochemistry 37, 15491-15502.
38. 38. Aertgeerts, K., De Bondt, H.L., De Ranter, C.J. & Declerck, P.J. (1995) Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1. Nat. Struct. Biol. 2. 891-897.
39. 39. Wright, H.T. & Scarsdale, J.N. (1995) Structural basis for serpin inhibitor activitty. Proteins 22, 210-225.